REQUEST A DEMO
Total
USD $0.00
Search more companies

Inventik Pharmaceuticals Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Inventik Pharmaceuticals Sp. z o.o. Profile Updated: January 11, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Inventik Pharmaceuticals Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on July 21, 2014. 5 (2014) employees currently work for Inventik Pharmaceuticals Sp. z o.o..

Headquarters
Ul. Aleja Jana Pawla Ii 80
Warsaw; Mazowieckie; Postal Code: 00-175

Contact Details: Purchase the Inventik Pharmaceuticals Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Inventik Pharmaceuticals Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Inventik Pharmaceuticals Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Inventik Pharmaceuticals Sp. z o.o. report to view the information.
Incorporation Date:
July 21, 2014
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
99%
Subsidiaries
Inpharmax Investments Sp. z o.o.
45.05%
Company Performance
Financial values in the chart are available after Inventik Pharmaceuticals Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total assets
0%
Total equity
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?